News
This was the stock's fifth consecutive day of losses.
West Pharmaceutical Services, Inc.'s Q2 results highlight growth driven by GLP-1 drugs and high-value products. Click for WST ...
StockStory.org on MSN3d
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q2 Earnings CallWest Pharmaceutical Services delivered a quarter that outperformed Wall Street’s expectations, reflecting renewed strength in ...
In Q2 2025, West Pharmaceutical's revenues increased by 9.17%, suggesting that the destocking effect is vanishing. Read why ...
StockStory.org on MSN11d
West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look ForHealthcare products company West Pharmaceutical Services (NYSE:WST) will be announcing earnings results this Thursday morning ...
Q2 2025 Earnings Call Transcript July 24, 2025 West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS ...
This was the stock's second consecutive day of losses.
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported revenue ahead of Wall Street’s expectations in ...
12d
TipRanks on MSNWest Pharmaceutical Appoints New CFO Robert McMahonWest Pharmaceutical Services ( ($WST) ) has provided an update. On July 21, 2025, West Pharmaceutical Services announced the appointment of Robert ...
Read about West Pharmaceutical Services Inc (WST:XNYS) stock and today's latest news and financial updates.
Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.
If you currently own WST and purchased prior to February 16, 2023 please contact Justin Kuehn, Esq. here , by email at ... or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results